Alain Jordan is the founder of Aleva Neurotherapeutics. Aleva Neurotherapeutics has raised $8M in total funding. Latest round: Series E.
Alain Jordan is the CEO of Aleva Neurotherapeutics, a Swiss company founded in 2008 in Lausanne. The company specializes in developing advanced Deep Brain Stimulation (DBS) technologies, particularly for treating neurological disorders such as Parkinson's disease and essential tremor. Aleva Neurotherapeutics has raised a total of $8 million through various funding rounds, with the latest being a Series E round.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide